Inventor
CHERNEY ROBERT J
US34 patents
⚠️ This page may combine multiple inventors who share the name “CHERNEY ROBERT J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
23 patentsUS7183270B2Feb 27, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO52 citations96
US7163937B2Jan 16, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO29 citations92
US7087604B2Aug 8, 2006
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO23 citations92
US10273259B2Apr 30, 2019
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO4 citations84
US8383812B2Feb 26, 2013
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
BRISTOL MYERS SQUIBB CO9 citations84
US7378409B2May 27, 2008
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO20 citations83
US9815859B2Nov 14, 2017
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO11 citations82
US7338947B2Mar 4, 2008
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations74
US7291615B2Nov 6, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO7 citations74
US7482335B2Jan 27, 2009
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations73
US11524959B1Dec 13, 2022
Indole and azaindole inhibitors of pad enzymes
BRISTOL MYERS SQUIBB CO3 citations72
US10023576B2Jul 17, 2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US8618101B2Dec 31, 2013
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
BRISTOL MYERS SQUIBB CO2 citations63
US7671062B2Mar 2, 2010
Modulators of chemokine receptor activity, crystalline forms and process
BRISTOL MYERS SQUIBB CO4 citations63
US10711020B2Jul 14, 2020
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations52
US8906920B2Dec 9, 2014
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7776884B2Aug 17, 2010
Cyclic derivatives as modulators of chemokine receptors activity
BRISTOL MYERS SQUIBB CO0 citations52
US7696205B2Apr 13, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US10934286B2Mar 2, 2021
Heterocyclic sulfones as ROR gamma modulators
BRISTOL MYERS SQUIBB CO0 citations51
US12473304B2Nov 18, 2025
Heterocyclic PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations43
US10214537B2Feb 26, 2019
Bicyclic heteroaryl amine compounds
BRISTOL MYERS SQUIBB CO0 citations41
DU PONT MERCK PHARMA
4 patentsUS5376664ADec 27, 1994
Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
DU PONT MERCK PHARMA11 citations73
US5585382ADec 17, 1996
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA7 citations71
US5416089AMay 16, 1995
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA12 citations71
US5359070AOct 25, 1994
Unsymmetrical bis-imides as anticancer agents
DU PONT MERCK PHARMA2 citations63
CHERNEY ROBERT J
3 patentsUS8629282B2Jan 14, 2014
Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases
CHERNEY ROBERT J9 citations82
US8642622B2Feb 4, 2014
Piperidinyl compound as a modulator of chemokine receptor activity
CHERNEY ROBERT J4 citations71
US8835470B2Sep 16, 2014
Mandelamide heterocyclic compounds
CHERNEY ROBERT J0 citations39